Medications for Multiple Sclerosis Secondary Progressive

13 results
  • aubagio - teriflunomide tablet, film coated

    (Teriflunomide)
    Genzyme Corporation
    Aubagio treats relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
  • betaseron - interferon beta-1b

    (Interferon Beta-1b)
    Bayer Healthcare Pharmaceuticals Inc.
    Betaseron treats relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
  • briumvi - ublituximab injection, solution, concentrate

    (Ublituximab)
    Tg Therapeutics, Inc.
    BRIUMVI treats relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
  • copaxone - glatiramer acetate injection, solution

    (Glatiramer Acetate)
    Teva Neuroscience, Inc.
    Copaxone treats relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
  • fingolimod - fingolimod capsule

    (Fingolimod)
    Biocon Pharma Inc.
    Fingolimod treats relapsing forms of multiple sclerosis (MS) in patients aged 10 and older, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
  • kesimpta - ofatumumab injection, solution

    (Ofatumumab)
    Novartis Pharmaceuticals Corporation
    Kesimpta treats relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
  • mavenclad - cladribine tablet

    (Cladribine)
    Emd Serono, Inc.
    MAVENCLAD treats relapsing forms of multiple sclerosis (MS) in adults, including relapsing-remitting and active secondary progressive disease. Generally recommended for patients with inadequate response to or intolerance of other MS treatments. Not recommended for clinically isolated syndrome (CIS).
  • plegridy - peginterferon beta-1a injection, solution

    (Peginterferon Beta-1a)
    Biogen Inc.
    Plegridy treats relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
  • rebif - interferon beta-1a

    (Interferon Beta-1a)
    Emd Serono, Inc.
    Rebif treats relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
  • tascenso odt - fingolimod lauryl sulfate tablet, orally disintegrating

    (Fingolimod Lauryl Sulfate)
    Cycle Pharmaceuticals Ltd
    TASCENSO ODT treats relapsing forms of multiple sclerosis (MS) in patients 10 and older, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.